amantadine has been researched along with Recrudescence in 44 studies
amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our results show that triple antiviral therapy for 48 weeks induced a sustained virological response in 33% of IFN-ribavirin nonresponders with recurrent hepatitis C." | 9.11 | Triple antiviral therapy with amantadine for IFN-ribavirin nonresponders with recurrent posttransplantation hepatitis C. ( Adham, M; Baulieux, J; Bizollon, T; Chevallier, M; Ducerf, C; Pradat, P; Trepo, C; Zoulim, F, 2005) |
| "Thirty-seven chronic hepatitis C patients with virological relapse (VR) after previous interferon-alpha (IFN) or IFN/ribavirin (Riba) therapy, were re-treated." | 9.10 | Chronic hepatitis C patients with a post-treatment virological relapse re-treated with an induction dose of 18 MU interferon-alpha in combination with ribavirin and amantadine: a two-arm randomized pilot study. ( Beld, MG; Dijkgraaf, MG; Reesink, HW; Sentjens, RE; Weegink, CJ, 2003) |
| "Interferon (IFN) alpha in combination with ribavirin (RIB) is standard therapy for patients with chronic hepatitis C virus (HCV) infection." | 9.09 | HCV RNA levels during therapy with amantadine in addition to interferon and ribavirin in chronic hepatitis C patients with previous nonresponse or response/relapse to interferon and ribavirin. ( Carlsson, T; Lindahl, K; Reichard, O; Schvarcz, R; Shev, S; Uhnoo, I; Wejstal, R, 2000) |
| "5 mg twice daily), amantadine (100 mg nocte), or with the H2 blockers cimetidine (800 mg nocte), and famotidine (40 mg nocte) in 124 patients with endoscopically proven duodenal ulcer (DU)." | 9.07 | Dopamine agonists prevent duodenal ulcer relapse. A comparative study with famotidine and cimetidine. ( Duvnjak, M; Jagic, V; Mise, S; Petek, M; Rotkvic, I; Rucman, R; Seiwerth, S; Sikiric, P; Suchanek, E; Zjacic-Rotkvic, V, 1991) |
| "In a randomised, double-blind trial on 20 patients with herpes simplex, tromantadine hydrochloride (TH) ointment had a significant therapeutic effect." | 9.05 | Tromantadine hydrochloride in the treatment of herpes simplex. Results of a double-blind therapeutic trial and an open prophylactic investigation. ( Hellgren, L; Hermann, LS, 1983) |
| "To evaluate the efficacy and safety of combination therapy with interferon-alpha2b (3 MU, 3 times weekly), ribavirin (600 mg daily) and amantadine (100 mg daily) in post-transplant hepatitis C." | 7.71 | Interferon-alpha plus ribavirin and amantadine in patients with post-transplant hepatitis C: results of a pilot study. ( Andreone, P; Bernardi, M; Biselli, M; Cavallari, A; Cursaro, C; D'Errico, A; Di Giammarino, L; Galli, S; Gramenzi, A; Grazi, GL; Jovine, E; Mazziotti, A, 2001) |
| "We report here the efficacy of amantadine hydrochloride for two patients with alternating hemiplegia of childhood (AHC) that did not respond to flunarizine." | 7.70 | Successful trial of amantadine hydrochloride for two patients with alternating hemiplegia of childhood. ( Funatsuka, M; Katsumori, H; Oguni, H; Osawa, M; Sone, K; Tanaka, T, 2000) |
| " Its combination with pegylated interferon and ribavirin needs further evaluation." | 6.77 | Randomized controlled trial of interferon gamma versus amantadine in combination with interferon alpha and ribavirin for hepatitis C genotype 3 non-responders and relapsers. ( Abbas, Z; Hamid, S; Jafri, W; Raza, S, 2012) |
| "Amantadine was given orally (200 mg/d) for 3 months." | 5.33 | Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting. ( Angelico, M; Anselmo, A; D'Andria, D; de Liguori Carino, N; de'Liguori Carino, N; Ielpo, B; Manzia, T; Muzi, F; Orlando, G; Sabato Ceraldi, S; Tariciotti, L; Tisone, G, 2005) |
| "Our results show that triple antiviral therapy for 48 weeks induced a sustained virological response in 33% of IFN-ribavirin nonresponders with recurrent hepatitis C." | 5.11 | Triple antiviral therapy with amantadine for IFN-ribavirin nonresponders with recurrent posttransplantation hepatitis C. ( Adham, M; Baulieux, J; Bizollon, T; Chevallier, M; Ducerf, C; Pradat, P; Trepo, C; Zoulim, F, 2005) |
| "Thirty-seven chronic hepatitis C patients with virological relapse (VR) after previous interferon-alpha (IFN) or IFN/ribavirin (Riba) therapy, were re-treated." | 5.10 | Chronic hepatitis C patients with a post-treatment virological relapse re-treated with an induction dose of 18 MU interferon-alpha in combination with ribavirin and amantadine: a two-arm randomized pilot study. ( Beld, MG; Dijkgraaf, MG; Reesink, HW; Sentjens, RE; Weegink, CJ, 2003) |
| "Interferon (IFN) alpha in combination with ribavirin (RIB) is standard therapy for patients with chronic hepatitis C virus (HCV) infection." | 5.09 | HCV RNA levels during therapy with amantadine in addition to interferon and ribavirin in chronic hepatitis C patients with previous nonresponse or response/relapse to interferon and ribavirin. ( Carlsson, T; Lindahl, K; Reichard, O; Schvarcz, R; Shev, S; Uhnoo, I; Wejstal, R, 2000) |
| "5 mg twice daily), amantadine (100 mg nocte), or with the H2 blockers cimetidine (800 mg nocte), and famotidine (40 mg nocte) in 124 patients with endoscopically proven duodenal ulcer (DU)." | 5.07 | Dopamine agonists prevent duodenal ulcer relapse. A comparative study with famotidine and cimetidine. ( Duvnjak, M; Jagic, V; Mise, S; Petek, M; Rotkvic, I; Rucman, R; Seiwerth, S; Sikiric, P; Suchanek, E; Zjacic-Rotkvic, V, 1991) |
| "In a randomised, double-blind trial on 20 patients with herpes simplex, tromantadine hydrochloride (TH) ointment had a significant therapeutic effect." | 5.05 | Tromantadine hydrochloride in the treatment of herpes simplex. Results of a double-blind therapeutic trial and an open prophylactic investigation. ( Hellgren, L; Hermann, LS, 1983) |
| "A significant proportion of chronic hepatitis C patients fails to achieve sustained virologic response even after treatment with the current, more potent, combination of pegylated interferon-alpha (IFNa) plus ribavirin." | 4.82 | Chronic hepatitis C and no response to antiviral therapy: potential current and future therapeutic options. ( Cholongitas, E; Papatheodoridis, GV, 2004) |
| " At present the recommended treatment for patients with chronic hepatitis C is a combination of pegylated interferon and ribavirin." | 4.82 | [Current treatment of hepatitis C virus infection]. ( Avci, A; Erhardt, A; Häussinger, D; Heintges, T; Lörke, J, 2005) |
| "This article presents a case of a 14-year-old female twin with schizophrenia who developed severe catatonia following treatment with olanzapine." | 3.79 | A case of catatonia in a 14-year-old girl with schizophrenia treated with electroconvulsive therapy. ( Buchmann, J; Häßler, F; Höppner, J; Pohl, B; Reis, O; Weirich, S, 2013) |
| "To evaluate the efficacy and safety of combination therapy with interferon-alpha2b (3 MU, 3 times weekly), ribavirin (600 mg daily) and amantadine (100 mg daily) in post-transplant hepatitis C." | 3.71 | Interferon-alpha plus ribavirin and amantadine in patients with post-transplant hepatitis C: results of a pilot study. ( Andreone, P; Bernardi, M; Biselli, M; Cavallari, A; Cursaro, C; D'Errico, A; Di Giammarino, L; Galli, S; Gramenzi, A; Grazi, GL; Jovine, E; Mazziotti, A, 2001) |
| "At present the treatment of hepatitis C virus infection (HCV) has improved because of combined treatment with interferon (IFN) and ribavirin." | 3.71 | Hepatitis C: who should you treat and how? ( Rodés, J; Sánchez Tapias, JM, 2002) |
| "We report here the efficacy of amantadine hydrochloride for two patients with alternating hemiplegia of childhood (AHC) that did not respond to flunarizine." | 3.70 | Successful trial of amantadine hydrochloride for two patients with alternating hemiplegia of childhood. ( Funatsuka, M; Katsumori, H; Oguni, H; Osawa, M; Sone, K; Tanaka, T, 2000) |
| " Its combination with pegylated interferon and ribavirin needs further evaluation." | 2.77 | Randomized controlled trial of interferon gamma versus amantadine in combination with interferon alpha and ribavirin for hepatitis C genotype 3 non-responders and relapsers. ( Abbas, Z; Hamid, S; Jafri, W; Raza, S, 2012) |
| "Antiviral therapy to treat recurrent hepatitis C infection after liver transplantation is controversial due to unresolved balance between benefits and harms." | 2.46 | Antiviral therapy for recurrent liver graft infection with hepatitis C virus. ( Burroughs, AK; Davidson, BR; Gurusamy, KS; Tsochatzis, E; Xirouchakis, E, 2010) |
| "The mechanism of recurrence is yet not fully elucidated and therapy still remains a problem." | 2.36 | [Herpes simplex]. ( Fanta, D, 1981) |
| "Amantadine was given orally (200 mg/d) for 3 months." | 1.33 | Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting. ( Angelico, M; Anselmo, A; D'Andria, D; de Liguori Carino, N; de'Liguori Carino, N; Ielpo, B; Manzia, T; Muzi, F; Orlando, G; Sabato Ceraldi, S; Tariciotti, L; Tisone, G, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (34.09) | 18.7374 |
| 1990's | 6 (13.64) | 18.2507 |
| 2000's | 19 (43.18) | 29.6817 |
| 2010's | 4 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hervey, WM | 1 |
| Stewart, JT | 1 |
| Catalano, G | 1 |
| Nair, S | 1 |
| Lipscomb, J | 1 |
| Eason, J | 1 |
| Gurusamy, KS | 1 |
| Tsochatzis, E | 1 |
| Xirouchakis, E | 1 |
| Burroughs, AK | 1 |
| Davidson, BR | 1 |
| Abbas, Z | 1 |
| Raza, S | 1 |
| Hamid, S | 1 |
| Jafri, W | 1 |
| Häßler, F | 1 |
| Reis, O | 1 |
| Weirich, S | 1 |
| Höppner, J | 1 |
| Pohl, B | 1 |
| Buchmann, J | 1 |
| Zoulim, F | 2 |
| Leroy, V | 1 |
| Hilleret, MN | 1 |
| Asselah, T | 1 |
| Weegink, CJ | 1 |
| Sentjens, RE | 1 |
| Beld, MG | 1 |
| Dijkgraaf, MG | 1 |
| Reesink, HW | 1 |
| Papatheodoridis, GV | 1 |
| Cholongitas, E | 1 |
| Davis, GL | 1 |
| Bizollon, T | 1 |
| Adham, M | 1 |
| Pradat, P | 1 |
| Chevallier, M | 1 |
| Ducerf, C | 1 |
| Baulieux, J | 1 |
| Trepo, C | 1 |
| Herrine, SK | 1 |
| Brown, RS | 1 |
| Bernstein, DE | 1 |
| Ondovik, MS | 1 |
| Lentz, E | 1 |
| Te, H | 1 |
| Muzi, F | 1 |
| Orlando, G | 1 |
| Ielpo, B | 1 |
| Anselmo, A | 1 |
| Sabato Ceraldi, S | 1 |
| de Liguori Carino, N | 1 |
| de'Liguori Carino, N | 1 |
| Manzia, T | 1 |
| D'Andria, D | 1 |
| Tariciotti, L | 1 |
| Angelico, M | 1 |
| Tisone, G | 1 |
| Lörke, J | 1 |
| Avci, A | 1 |
| Erhardt, A | 1 |
| Heintges, T | 1 |
| Häussinger, D | 1 |
| Hoepffner, N | 1 |
| Paul, KA | 1 |
| Nikodem, AB | 1 |
| Teuber, G | 1 |
| Shobugawa, Y | 1 |
| Saito, R | 1 |
| Sato, I | 1 |
| Li, D | 1 |
| Suzuki, Y | 1 |
| Sasaki, A | 1 |
| Sato, M | 1 |
| Suzuki, H | 1 |
| Nicholson, KG | 1 |
| Oxford, JS | 1 |
| Galbraith, A | 1 |
| Fanta, D | 1 |
| Hellgren, L | 1 |
| Hermann, LS | 1 |
| Przybilla, B | 1 |
| Balda, BR | 1 |
| Fisher, DA | 1 |
| Hausner, RS | 1 |
| Terao, T | 1 |
| Noveske, FG | 1 |
| Botros, S | 1 |
| Mahmoud, S | 1 |
| Hassan, S | 1 |
| Ibrahim, A | 1 |
| Zidek, Z | 1 |
| Masek, K | 1 |
| Renner, EL | 1 |
| Carlsson, T | 1 |
| Lindahl, K | 1 |
| Schvarcz, R | 1 |
| Wejstal, R | 1 |
| Uhnoo, I | 1 |
| Shev, S | 1 |
| Reichard, O | 1 |
| Sareen, D | 1 |
| Kumar, V | 1 |
| Sone, K | 1 |
| Oguni, H | 1 |
| Katsumori, H | 1 |
| Funatsuka, M | 1 |
| Tanaka, T | 1 |
| Osawa, M | 1 |
| Kazui, H | 1 |
| Mori, E | 1 |
| Hashimoto, M | 1 |
| Hirono, N | 1 |
| Andreone, P | 1 |
| Gramenzi, A | 1 |
| Cursaro, C | 1 |
| Biselli, M | 1 |
| Di Giammarino, L | 1 |
| Grazi, GL | 1 |
| Jovine, E | 1 |
| D'Errico, A | 1 |
| Galli, S | 1 |
| Mazziotti, A | 1 |
| Cavallari, A | 1 |
| Bernardi, M | 1 |
| Sánchez Tapias, JM | 1 |
| Rodés, J | 1 |
| Jacoby, I | 1 |
| Mandell, LA | 1 |
| Weinstein, L | 1 |
| Mindham, RH | 1 |
| Marsden, CD | 1 |
| Parkes, JD | 1 |
| Berger-Roscher, J | 1 |
| Meyer-Rohn, J | 1 |
| Sikiric, P | 1 |
| Rotkvic, I | 1 |
| Mise, S | 1 |
| Petek, M | 1 |
| Rucman, R | 1 |
| Seiwerth, S | 1 |
| Zjacic-Rotkvic, V | 1 |
| Duvnjak, M | 1 |
| Jagic, V | 1 |
| Suchanek, E | 1 |
| Pritchard, MH | 1 |
| Munro, J | 1 |
| Hermesh, H | 1 |
| Sirota, P | 1 |
| Eviatar, J | 1 |
| Wilson, JA | 1 |
| Farquhar, DL | 1 |
| Primrose, WR | 1 |
| Smith, RG | 1 |
| Plaut, GS | 1 |
| DeVoe, AG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Interferon-gamma With Interferon Alpha and Ribavirin for Hepatitis C Patients Who Are Non-responders to Interferon Alpha Plus Ribavirin[NCT00538811] | Phase 2/Phase 3 | 40 participants (Anticipated) | Interventional | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
14 reviews available for amantadine and Recrudescence
| Article | Year |
|---|---|
Antiviral therapy for recurrent liver graft infection with hepatitis C virus.
Topics: Amantadine; Antiviral Agents; Hepacivirus; Hepatitis C; Humans; Interferons; Liver Transplantation; | 2010 |
[Treatment of patients with chronic hepatitis C who relapsed or did not respond to a previous treatment].
Topics: Amantadine; Antiviral Agents; Clinical Enzyme Tests; Clinical Trials as Topic; Drug Therapy, Combina | 2002 |
[Evaluation of response to treatment in chronic hepatitis C].
Topics: Alanine Transaminase; Amantadine; Antiviral Agents; Biopsy; Carcinoma, Hepatocellular; Clinical Enzy | 2002 |
Consensus conference. Treatment of hepatitis C.
Topics: Adult; Aged; Alcoholism; Amantadine; Antiviral Agents; Body Weight; Child; Drug Therapy, Combination | 2002 |
[Chronic hepatitis C: what to do if the first treatment failed?].
Topics: Amantadine; Animals; Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Ethanol | 2002 |
Chronic hepatitis C and no response to antiviral therapy: potential current and future therapeutic options.
Topics: Amantadine; Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon-al | 2004 |
Treatment of acute and chronic hepatitis C.
Topics: Amantadine; Antiviral Agents; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; M | 1997 |
[Current treatment of hepatitis C virus infection].
Topics: Acute Disease; Amantadine; Animals; Antiviral Agents; Hepacivirus; Hepatitis B; Hepatitis C; Hepatit | 2005 |
[High dose repeat therapy in previously treated patients with chronic hepatitis C].
Topics: Amantadine; Antiviral Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hepatitis | 2006 |
Antiviral therapy. Respiratory infections, genital herpes, and herpetic keratitis.
Topics: Acyclovir; Adult; Amantadine; Antiviral Agents; Child; Female; Herpes Genitalis; Humans; Idoxuridine | 1984 |
Antiviral activity of amantadine: a review of laboratory and clinical data.
Topics: Amantadine; Animals; Antiviral Agents; Culture Techniques; Drug Resistance, Microbial; Hemagglutinin | 1980 |
[Herpes simplex].
Topics: Adolescent; Adult; Amantadine; Antigens, Viral; Cell Transformation, Viral; Female; Foscarnet; Herpe | 1981 |
[Therapy of chronic hepatitis C: facing a breakthrough?].
Topics: Amantadine; Clinical Trials as Topic; Combined Modality Therapy; Hepatitis C, Chronic; Humans; Inter | 1998 |
The practical management of ocular infections. II. Viral infections.
Topics: Amantadine; Antifungal Agents; Corneal Transplantation; Corneal Ulcer; Epithelium; Eye Diseases; Her | 1972 |
13 trials available for amantadine and Recrudescence
| Article | Year |
|---|---|
Efficacy of interferon based antiviral therapy for recurrent hepatitis C in patients who received steroid free immunosuppression for liver transplantation.
Topics: Amantadine; Antibodies, Monoclonal; Antilymphocyte Serum; Antiviral Agents; Disease Progression; Dru | 2008 |
Randomized controlled trial of interferon gamma versus amantadine in combination with interferon alpha and ribavirin for hepatitis C genotype 3 non-responders and relapsers.
Topics: Adult; Amantadine; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interfe | 2012 |
Chronic hepatitis C patients with a post-treatment virological relapse re-treated with an induction dose of 18 MU interferon-alpha in combination with ribavirin and amantadine: a two-arm randomized pilot study.
Topics: Adult; Aged; Amantadine; Antiviral Agents; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis | 2003 |
Triple antiviral therapy with amantadine for IFN-ribavirin nonresponders with recurrent posttransplantation hepatitis C.
Topics: Adult; Amantadine; Antiviral Agents; Blood Cell Count; Drug Therapy, Combination; Female; Hepaciviru | 2005 |
Peginterferon alpha-2a combination therapies in chronic hepatitis C patients who relapsed after or had a viral breakthrough on therapy with standard interferon alpha-2b plus ribavirin: a pilot study of efficacy and safety.
Topics: Alanine Transaminase; Amantadine; Antiviral Agents; Drug Therapy, Combination; Female; Genotype; Hem | 2005 |
Recurrence and persistence of fever in children who developed amantadine-resistant influenza viruses after treatment.
Topics: Amantadine; Animals; Antiviral Agents; Body Temperature; Child, Preschool; Demography; Dogs; Drug Re | 2008 |
Tromantadine hydrochloride in the treatment of herpes simplex. Results of a double-blind therapeutic trial and an open prophylactic investigation.
Topics: Administration, Oral; Amantadine; Antiviral Agents; Clinical Trials as Topic; Double-Blind Method; E | 1983 |
HCV RNA levels during therapy with amantadine in addition to interferon and ribavirin in chronic hepatitis C patients with previous nonresponse or response/relapse to interferon and ribavirin.
Topics: Adult; Amantadine; Antiviral Agents; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Ch | 2000 |
Psychiatric symptoms during l-dopa therapy for Parkinson's disease and their relationship to physical disability.
Topics: Aged; Amantadine; Carbidopa; Clinical Trials as Topic; Depression; Dose-Response Relationship, Drug; | 1976 |
[Outpatient testing of Viru-Merz in herpes simples infections of the skin].
Topics: Adolescent; Adult; Aged; Amantadine; Antiviral Agents; Clinical Trials as Topic; Dimethylamines; Fem | 1975 |
Dopamine agonists prevent duodenal ulcer relapse. A comparative study with famotidine and cimetidine.
Topics: Adult; Aged; Amantadine; Bromocriptine; Cimetidine; Duodenal Ulcer; Famotidine; Female; Humans; Male | 1991 |
Successful treatment of juvenile chronic arthritis with a specific antiviral agent.
Topics: Adult; Amantadine; Antibodies, Viral; Arthritis, Juvenile; Double-Blind Method; Female; Humans; Infl | 1989 |
Effectiveness of amantadine in reducing relapses in multiple sclerosis.
Topics: Adult; Amantadine; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; | 1987 |
17 other studies available for amantadine and Recrudescence
| Article | Year |
|---|---|
Diagnosis and management of periodic catatonia.
Topics: Amantadine; Antipsychotic Agents; Catatonia; Humans; Male; Middle Aged; Periodicity; Recurrence | 2013 |
A case of catatonia in a 14-year-old girl with schizophrenia treated with electroconvulsive therapy.
Topics: Adolescent; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Catatonia; Comb | 2013 |
Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting.
Topics: Amantadine; Antiviral Agents; Azathioprine; Cyclosporine; Female; Hepatitis C; Humans; Immunosuppres | 2005 |
[Allergic contact dermatitis due to tromantadin (author's transl)].
Topics: Adolescent; Adult; Amantadine; Cheilitis; Child; Drug Eruptions; Female; Herpes Simplex; Humans; In | 1980 |
Recurrent herpes simplex sciatica and its treatment with amantadine hydrochloride.
Topics: Adult; Amantadine; Female; Herpes Simplex; Humans; Menstruation; Middle Aged; Neuralgia; Recurrence; | 1982 |
Amantadine-associated recurrence of psychosis.
Topics: Aged; Amantadine; Female; Humans; Parkinson Disease; Psychoses, Substance-Induced; Recurrence; Schiz | 1980 |
Titration of serotonin reuptake blockers.
Topics: Amantadine; Drug Administration Schedule; Fluoxetine; Humans; Mental Disorders; Recurrence; Selectiv | 1993 |
Breakthrough panic after amantadine treatment in a Parkinson's disease patient.
Topics: Adult; Amantadine; Humans; Male; Panic Disorder; Parkinson Disease; Recurrence | 1996 |
Effect of adamantylamide dipeptide on reinfection resistance after primary infection eradication in experimental Schistosomiasis mansoni.
Topics: Adjuvants, Immunologic; Amantadine; Animals; Antibody Formation; Antiplatyhelmintic Agents; Dipeptid | 1996 |
Amantadine treatment in cerebellar ataxia.
Topics: Amantadine; Cerebellar Ataxia; Dopamine Agents; Female; Humans; Middle Aged; Recurrence | 2001 |
Successful trial of amantadine hydrochloride for two patients with alternating hemiplegia of childhood.
Topics: Adult; Amantadine; Dopamine Agents; Female; Glutamic Acid; Hemiplegia; Humans; Infant; Male; Recepto | 2000 |
Phobia after bilateral thalamic hemorrhage.
Topics: Amantadine; Cerebral Hemorrhage; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Phobic Disor | 2001 |
Interferon-alpha plus ribavirin and amantadine in patients with post-transplant hepatitis C: results of a pilot study.
Topics: Aged; Amantadine; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interfer | 2001 |
Hepatitis C: who should you treat and how?
Topics: Amantadine; Antiviral Agents; Decision Making; Decision Trees; Drug Therapy, Combination; Hepatitis | 2002 |
The chemoprophylaxis of infection. A brief review of recent studies.
Topics: Adult; Aged; Amantadine; Anti-Bacterial Agents; Bacterial Infections; Bone and Bones; Cardiac Surgic | 1978 |
Recurrent neuroleptic malignant syndrome due to haloperidol and amantadine.
Topics: Aged; Amantadine; Dementia; Drug Therapy, Combination; Haloperidol; Humans; Male; Neuroleptic Malign | 1989 |
Long term amantadine treatment. The danger of withdrawal.
Topics: Aged; Amantadine; Female; Humans; Male; Parkinson Disease; Recurrence | 1987 |